Familial colorectal cancer: A concept revisited

Colorectal Disease

Volumn 11, Issue 2, 2009, Pages 133-137

  Martellucci, Jacopo ^a   Civitelli, S ^a   Dhamo, A ^a   Tanzini, G ^a  

^a UNIVERSITY OF SIENA   (Italy)

Author keywords

Colorectal cancer; Familial colorectal cancer; FAP; Gene mutation; HNPCC; Inherited syndromes

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; COLORECTAL CANCER; CONTROLLED STUDY; FAMILIAL CANCER; FAMILIAL COLON POLYPOSIS; FAMILY HISTORY; FEMALE; GENE MUTATION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC RISK; HUMAN; MAJOR CLINICAL STUDY; MALE; ONSET AGE; PRIORITY JOURNAL; RISK ASSESSMENT;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; ITALY; MALE; MIDDLE AGED; PEDIGREE; PREVALENCE; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 58449095239     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2008.01561.x     Document Type: Article

References (27)

1. Winawer SJ, Zauber AG, Gerdes H, O'Brien MJ, Gottlieb LS, Sternberg SS, Bond JH, Waye JD, Schapiro M, Panish JF. Risk of colorectal cancer in the families of patients with adenomatous polyps. National Polyp Study Workgroup. N Engl J Med 1996; 334: 82-7.
2. Burt RW, Petersen GM. (1996) Familial colorectal cancer: Diagnosis and management. In: Prevention and Early Detection of Colorectal Cancer (eds Young GP, Rozen P, Levin B)., pp. 171-94. WB Saunders, London.
3. Johns LE, Houlston RS. A systematic review and meta-analysis of familial colorectal cancer risk. Am J Gastroenterol 2001; 96: 2992-3003.
4. Renkonen-Sinisalo L, Aarnio M, Mecklin JP, Järvinen HJ. Surveillance improves survival of colorectal cancer in patients with hereditary nonpolyposis colorectal cancer. Cancer Detect Prev 2000; 24: 137-42.
5. Winawer S, Fletcher R, Rex D, Bond J, Burt R, Ferrucci J, Ganiats T, Levin T, Woolf S, Johnson D. Colorectal cancer screening and surveillance: Clinical guidelines and rationale. Update based on new evidence. Gastroenterology 2003; 124: 544-60.
6. Burt RW, Bishop DT, Lynch HT, Rozen P, Winawer S. Risk and surveillance of individuals with heritable factors for colorectal cancer. WHO Collaborating Centre for the Prevention of Colorectal Cancer. Bull World Health Organ 1990; 68: 655-65.
7. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, Koskenvuo M, Pukkala E, Skytthe A, Hemminki K. Environmental and heritable factors in the causation of cancer: Analyses of cohorts of twins from Sweden, Denmark and Finland. N Eng J Med 2000; 343: 78-85.
8. Smith RA, Cokkinides V, Eyre HJ. American cancer guidelines for the early detection of cancer, 2006. Cancer J Clin 2006; 56: 11-25.
9. Vasen H, Moslein G, Alonso A et al. European guidelines for the clinical management of Lynch syndrome (HNPCC). J Med Genet 2007; 44(6): 353-62.
10. Winawer S, Fletcher R, Miller L et al. Colorectal cancer screening: clinical guidelines and rationale. Gastroenterology 1997; 112: 594-642.
11. Church JM. A scoring system for the strenght of a family history of colorectal cancer. Dis Colon Rectum 2005; 48: 889-96.
12. Okkels H, Sunde L, Lindorff-Larsen K, Thorlacius-Ussing O, Gandrup P, Lindebjerg J, Stubbeteglbjaerg P, Oestergaard JR, Nielsen FC, Krarup HB. Polyposis and early cancer in a patient with low penetrant mutations in MSH6 and APC: Hereditary colorectal cancer as a polygenic trait. Int J Colorectal Dis 2006; 21: 847-50.
13. Goodfellow PJ, Buttin BM, Herzog TJ, Rader JS, Gibb RK, Swisher E, Look K, Walls KC, Fan MY, Mutch DG. Prevalence of defective DNA mismatch repair and MSH6 mutation in an unselected series of endometrial cancers. Proc Natl Acad Sci USA 2003; 100: 5908-13.
14. Wagner A, Hendriks Y, Meijers-Heijboer EJ et al. Atypical HNPCC owing to MSH6 germline mutations: Analysis of a large Dutch pedigree. J Med Genet 2001; 38: 318-22.
15. Wijnen J, de Leeuw W, Vasen HF et al. Familial endometrial cancer in female carriers of MSH6 mutations. Nat Genet 1999; 23: 142-4.
16. Sampson JR, Dolwani S, Jones S et al. Autosomal recessive adenomatous polyposis due to inherited mutations of MYH. Lancet 2003; 362: 39-41.
17. Casey G, Lindor NM, Papadopoulos N et al. Colon Cancer Family Registry. Conversion analysis for mutation detection in MLH1 and MSH2 in patients with colorectal cancer. JAMA 2005; 293: 799-809.
18. Nystrom-Lahti M, Wu Y, Moisio AL et al. DNA mismatch repair gene mutations in 55 kindreds with verified or putative hereditary non-polyposis colorectal cancer. Hum Mol Genet 1996; 348: 763-9.
19. Syngal S, Fox EA, Eng C, Kolodner RD, Garber JE. Sensitivity and specificity of clinical criteria for hereditary non-polyposis colorectal cancer associated mutations in MSH2 and MLH1. J Med Genet 2000; 37: 641-5.
20. Aaltonen LA, Salovaara R, Kristo P et al. Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Eng J Med 1998; 338: 1481-7.
21. Ziogas A, Anton-Culver H. Validation of family history data in cancer family registries. Am J Prev Med 2003; 24: 190-8.
22. Airewele G, Adatto P, Cunningham J, Mastromarino C, Spencer C, Sharp M, Sigurdson A, Bondy M. Family history of cancer in patients with glioma: a validation study of accuracy. J Natl Cancer Inst 1998; 90: 543-4.
23. Johns LE, Kee F, Collins BJ, Patterson CC, Houlston RS. Colorectal cancer mortality in first-degree relatives of early onset colorectal cance cases. Dis Colon Rectum 2002; 45: 681-6.
24. Andrieu N, Launoy G, Guillois R, Ory-Paoletti C, Gignoux M. Estimation of familial relative risk of cancer by site from a French population based family study on colorectal cancer (CCREF study). Gut 2004; 53: 1322-8.
25. Vasen HF, Mecklin JP, Khan PM et al. The International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC). Dis Colon Rectum 1991; 34(5): 424-5.
26. Vasen HF, Watson P, Mecklin JP et al. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116(6): 1453-6.
27. Umar A, Boland CR, Terdiman JP et al. Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 2004; 96(4): 261-8.